MajesTEC-4

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation - MajesTEC-4

Near Add Your Location

Sorting 44 by

University of Colorado Cancer Center
Anschutz Cancer Pavilion
Aurora, CO
  • Not currently accepting
Colorado Blood Cancer Institute
Sarah Cannon at Presbyterian/St. Luke's Medical Center (HealthONE)
Denver, CO
  • Not currently accepting
Florida Hospital Medical Center
Orlando, FL
  • Not currently accepting
Moffitt Cancer Center
Magnolia Campus
Tampa, FL
  • Not currently accepting
Simon Cancer Center
Indiana University
Indianapolis, IN
  • Not currently accepting
University of Maryland Medical Center
Marlene and Stewart Greenebaum Comprehensive Cancer Center
Baltimore, MD
  • Not currently accepting

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.